Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003186 · ClinicalTrials.gov registry record · NA
Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer
A NA study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
NCT00003186 is a NA study that has completed, run by Roswell Park Cancer Institute.
The verdict
NCT00003186, a NA study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
RATIONALE: Diagnostic procedures, such as lymphography, may improve the identification of patients with metastatic colorectal cancer. PURPOSE: Clinical trial to study the effectiveness of lymphography in determining the presence or absence of metastatic colorectal cancer in patients.
Interventions
- PROCEDURE lymphangiography
- PROCEDURE sentinel lymph node biopsy
- DRUG isosulfan blue
Trial Details
| Field | Value |
|---|---|
| Start Date | 1997-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003186
The ClinicalTrials.gov registry entry for NCT00003186 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which lymphangiography is the first listed.
NCT00003186 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003186 about?
NCT00003186 is a clinical study titled "Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer". RATIONALE: Diagnostic procedures, such as lymphography, may improve the identification of patients with metastatic colorectal cancer. PURPOSE: Clinical trial to study the effectiveness of lymphography in determining the presence or absence of metastatic colorectal cancer in patients.
What is the current status of trial NCT00003186?
This trial is currently completed. It is a NA study. The study started on 1997-04.
What interventions are being tested in trial NCT00003186?
The interventions under investigation include: lymphangiography (PROCEDURE), sentinel lymph node biopsy (PROCEDURE), isosulfan blue (DRUG).
Who is sponsoring clinical trial NCT00003186?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.